BCTX
Briacell Therapeutics
BCTX
BCTX
22 hedge funds and large institutions have $14.8M invested in Briacell Therapeutics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 0.11% → 0.11% (-0.01%)
13% less capital invested
Capital invested by funds: $17M → $14.8M (-$2.2M)
Holders
22
Holding in Top 10
1
Calls
$4.6M
Puts
$243K
Top Buyers
| 1 | +$203K | |
| 2 | +$176K | |
| 3 | +$97.1K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$87.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$87.5K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$427K | |
| 3 | -$156K | |
| 4 |
RAM
Redmond Asset Management
Henrico,
Virginia
|
-$25.5K |
| 5 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
-$10.5K |